Precision Cancer Diagnostic Tests Market, Global Outlook and Forecast 2022-2028

April 2022 | 110 pages | ID: P5931A6A966DEN
Market Monitor Global

Abstracts

Precision cancer tests encompass imaging and in vitro diagnostic (IVD) products and procedures that directly detect malignancies in patient samples or in the patients themselves.

This report contains market size and forecasts of Precision Cancer Diagnostic Tests in Global, including the following market information:

Global Precision Cancer Diagnostic Tests Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Precision Cancer Diagnostic Tests market was valued at 4268.7 million in 2021 and is projected to reach US$ 9414.6 million by 2028, at a CAGR of 12.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Imaging Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Precision Cancer Diagnostic Tests include Abbott Laboratories, Agilent Technologies, Becton Dickinson and Company, Bio-Rad Laboratories, Biocartis N.V., Biocept, bioMerieux SA, Canon Medical Systems Corporation and Cynvenio Biosystems, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Precision Cancer Diagnostic Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Precision Cancer Diagnostic Tests Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Precision Cancer Diagnostic Tests Market Segment Percentages, by Type, 2021 (%)

• Imaging
• Molecular
• Histology/Cytology
• Tumor Marker Immunoassays
• POC Colon Cancer Tests

Global Precision Cancer Diagnostic Tests Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Precision Cancer Diagnostic Tests Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Other

Global Precision Cancer Diagnostic Tests Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Precision Cancer Diagnostic Tests Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Precision Cancer Diagnostic Tests revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Precision Cancer Diagnostic Tests revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• Agilent Technologies
• Becton Dickinson and Company
• Bio-Rad Laboratories
• Biocartis N.V.
• Biocept
• bioMerieux SA
• Canon Medical Systems Corporation
• Cynvenio Biosystems
• Danaher Corporation
• Epigenomics AG
• Exosome Diagnostics
• Foundation Medicine
• General Electric Company
• Genomic Health
• Hologic
• Illumina
• Menarini Silicon Biosystems SpA
• Myriad Genetics
• NanoString Technologies
• Ortho Clinical Diagnostics
• QIAGEN N.V.
• Randox Laboratories Ltd.
• Roche Holding AG
• Royal Philips N.V.
• Siemens AG
• Thermo Fisher Scientific
• Vela Diagnostics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Precision Cancer Diagnostic Tests Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Precision Cancer Diagnostic Tests Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PRECISION CANCER DIAGNOSTIC TESTS OVERALL MARKET SIZE

2.1 Global Precision Cancer Diagnostic Tests Market Size: 2021 VS 2028
2.2 Global Precision Cancer Diagnostic Tests Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Precision Cancer Diagnostic Tests Players in Global Market
3.2 Top Global Precision Cancer Diagnostic Tests Companies Ranked by Revenue
3.3 Global Precision Cancer Diagnostic Tests Revenue by Companies
3.4 Top 3 and Top 5 Precision Cancer Diagnostic Tests Companies in Global Market, by Revenue in 2021
3.5 Global Companies Precision Cancer Diagnostic Tests Product Type
3.6 Tier 1, Tier 2 and Tier 3 Precision Cancer Diagnostic Tests Players in Global Market
  3.6.1 List of Global Tier 1 Precision Cancer Diagnostic Tests Companies
  3.6.2 List of Global Tier 2 and Tier 3 Precision Cancer Diagnostic Tests Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Precision Cancer Diagnostic Tests Market Size Markets, 2021 & 2028
  4.1.2 Imaging
  4.1.3 Molecular
  4.1.4 Histology/Cytology
  4.1.5 Tumor Marker Immunoassays
  4.1.6 POC Colon Cancer Tests
4.2 By Type - Global Precision Cancer Diagnostic Tests Revenue & Forecasts
  4.2.1 By Type - Global Precision Cancer Diagnostic Tests Revenue, 2017-2022
  4.2.2 By Type - Global Precision Cancer Diagnostic Tests Revenue, 2023-2028
  4.2.3 By Type - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Precision Cancer Diagnostic Tests Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Other
5.2 By Application - Global Precision Cancer Diagnostic Tests Revenue & Forecasts
  5.2.1 By Application - Global Precision Cancer Diagnostic Tests Revenue, 2017-2022
  5.2.2 By Application - Global Precision Cancer Diagnostic Tests Revenue, 2023-2028
  5.2.3 By Application - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Precision Cancer Diagnostic Tests Market Size, 2021 & 2028
6.2 By Region - Global Precision Cancer Diagnostic Tests Revenue & Forecasts
  6.2.1 By Region - Global Precision Cancer Diagnostic Tests Revenue, 2017-2022
  6.2.2 By Region - Global Precision Cancer Diagnostic Tests Revenue, 2023-2028
  6.2.3 By Region - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Precision Cancer Diagnostic Tests Revenue, 2017-2028
  6.3.2 US Precision Cancer Diagnostic Tests Market Size, 2017-2028
  6.3.3 Canada Precision Cancer Diagnostic Tests Market Size, 2017-2028
  6.3.4 Mexico Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Precision Cancer Diagnostic Tests Revenue, 2017-2028
  6.4.2 Germany Precision Cancer Diagnostic Tests Market Size, 2017-2028
  6.4.3 France Precision Cancer Diagnostic Tests Market Size, 2017-2028
  6.4.4 U.K. Precision Cancer Diagnostic Tests Market Size, 2017-2028
  6.4.5 Italy Precision Cancer Diagnostic Tests Market Size, 2017-2028
  6.4.6 Russia Precision Cancer Diagnostic Tests Market Size, 2017-2028
  6.4.7 Nordic Countries Precision Cancer Diagnostic Tests Market Size, 2017-2028
  6.4.8 Benelux Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Precision Cancer Diagnostic Tests Revenue, 2017-2028
  6.5.2 China Precision Cancer Diagnostic Tests Market Size, 2017-2028
  6.5.3 Japan Precision Cancer Diagnostic Tests Market Size, 2017-2028
  6.5.4 South Korea Precision Cancer Diagnostic Tests Market Size, 2017-2028
  6.5.5 Southeast Asia Precision Cancer Diagnostic Tests Market Size, 2017-2028
  6.5.6 India Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Precision Cancer Diagnostic Tests Revenue, 2017-2028
  6.6.2 Brazil Precision Cancer Diagnostic Tests Market Size, 2017-2028
  6.6.3 Argentina Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Precision Cancer Diagnostic Tests Revenue, 2017-2028
  6.7.2 Turkey Precision Cancer Diagnostic Tests Market Size, 2017-2028
  6.7.3 Israel Precision Cancer Diagnostic Tests Market Size, 2017-2028
  6.7.4 Saudi Arabia Precision Cancer Diagnostic Tests Market Size, 2017-2028
  6.7.5 UAE Precision Cancer Diagnostic Tests Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott Laboratories
  7.1.1 Abbott Laboratories Corporate Summary
  7.1.2 Abbott Laboratories Business Overview
  7.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Major Product Offerings
  7.1.4 Abbott Laboratories Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.1.5 Abbott Laboratories Key News
7.2 Agilent Technologies
  7.2.1 Agilent Technologies Corporate Summary
  7.2.2 Agilent Technologies Business Overview
  7.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Major Product Offerings
  7.2.4 Agilent Technologies Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.2.5 Agilent Technologies Key News
7.3 Becton Dickinson and Company
  7.3.1 Becton Dickinson and Company Corporate Summary
  7.3.2 Becton Dickinson and Company Business Overview
  7.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Major Product Offerings
  7.3.4 Becton Dickinson and Company Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.3.5 Becton Dickinson and Company Key News
7.4 Bio-Rad Laboratories
  7.4.1 Bio-Rad Laboratories Corporate Summary
  7.4.2 Bio-Rad Laboratories Business Overview
  7.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Major Product Offerings
  7.4.4 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.4.5 Bio-Rad Laboratories Key News
7.5 Biocartis N.V.
  7.5.1 Biocartis N.V. Corporate Summary
  7.5.2 Biocartis N.V. Business Overview
  7.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Major Product Offerings
  7.5.4 Biocartis N.V. Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.5.5 Biocartis N.V. Key News
7.6 Biocept
  7.6.1 Biocept Corporate Summary
  7.6.2 Biocept Business Overview
  7.6.3 Biocept Precision Cancer Diagnostic Tests Major Product Offerings
  7.6.4 Biocept Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.6.5 Biocept Key News
7.7 bioMerieux SA
  7.7.1 bioMerieux SA Corporate Summary
  7.7.2 bioMerieux SA Business Overview
  7.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Major Product Offerings
  7.7.4 bioMerieux SA Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.7.5 bioMerieux SA Key News
7.8 Canon Medical Systems Corporation
  7.8.1 Canon Medical Systems Corporation Corporate Summary
  7.8.2 Canon Medical Systems Corporation Business Overview
  7.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Major Product Offerings
  7.8.4 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.8.5 Canon Medical Systems Corporation Key News
7.9 Cynvenio Biosystems
  7.9.1 Cynvenio Biosystems Corporate Summary
  7.9.2 Cynvenio Biosystems Business Overview
  7.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Major Product Offerings
  7.9.4 Cynvenio Biosystems Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.9.5 Cynvenio Biosystems Key News
7.10 Danaher Corporation
  7.10.1 Danaher Corporation Corporate Summary
  7.10.2 Danaher Corporation Business Overview
  7.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Major Product Offerings
  7.10.4 Danaher Corporation Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.10.5 Danaher Corporation Key News
7.11 Epigenomics AG
  7.11.1 Epigenomics AG Corporate Summary
  7.11.2 Epigenomics AG Business Overview
  7.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Major Product Offerings
  7.11.4 Epigenomics AG Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.11.5 Epigenomics AG Key News
7.12 Exosome Diagnostics
  7.12.1 Exosome Diagnostics Corporate Summary
  7.12.2 Exosome Diagnostics Business Overview
  7.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Major Product Offerings
  7.12.4 Exosome Diagnostics Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.12.5 Exosome Diagnostics Key News
7.13 Foundation Medicine
  7.13.1 Foundation Medicine Corporate Summary
  7.13.2 Foundation Medicine Business Overview
  7.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Major Product Offerings
  7.13.4 Foundation Medicine Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.13.5 Foundation Medicine Key News
7.14 General Electric Company
  7.14.1 General Electric Company Corporate Summary
  7.14.2 General Electric Company Business Overview
  7.14.3 General Electric Company Precision Cancer Diagnostic Tests Major Product Offerings
  7.14.4 General Electric Company Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.14.5 General Electric Company Key News
7.15 Genomic Health
  7.15.1 Genomic Health Corporate Summary
  7.15.2 Genomic Health Business Overview
  7.15.3 Genomic Health Precision Cancer Diagnostic Tests Major Product Offerings
  7.15.4 Genomic Health Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.15.5 Genomic Health Key News
7.16 Hologic
  7.16.1 Hologic Corporate Summary
  7.16.2 Hologic Business Overview
  7.16.3 Hologic Precision Cancer Diagnostic Tests Major Product Offerings
  7.16.4 Hologic Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.16.5 Hologic Key News
7.17 Illumina
  7.17.1 Illumina Corporate Summary
  7.17.2 Illumina Business Overview
  7.17.3 Illumina Precision Cancer Diagnostic Tests Major Product Offerings
  7.17.4 Illumina Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.17.5 Illumina Key News
7.18 Menarini Silicon Biosystems SpA
  7.18.1 Menarini Silicon Biosystems SpA Corporate Summary
  7.18.2 Menarini Silicon Biosystems SpA Business Overview
  7.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Major Product Offerings
  7.18.4 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.18.5 Menarini Silicon Biosystems SpA Key News
7.19 Myriad Genetics
  7.19.1 Myriad Genetics Corporate Summary
  7.19.2 Myriad Genetics Business Overview
  7.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Major Product Offerings
  7.19.4 Myriad Genetics Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.19.5 Myriad Genetics Key News
7.20 NanoString Technologies
  7.20.1 NanoString Technologies Corporate Summary
  7.20.2 NanoString Technologies Business Overview
  7.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Major Product Offerings
  7.20.4 NanoString Technologies Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.20.5 NanoString Technologies Key News
7.21 Ortho Clinical Diagnostics
  7.21.1 Ortho Clinical Diagnostics Corporate Summary
  7.21.2 Ortho Clinical Diagnostics Business Overview
  7.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Major Product Offerings
  7.21.4 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.21.5 Ortho Clinical Diagnostics Key News
7.22 QIAGEN N.V.
  7.22.1 QIAGEN N.V. Corporate Summary
  7.22.2 QIAGEN N.V. Business Overview
  7.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Major Product Offerings
  7.22.4 QIAGEN N.V. Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.22.5 QIAGEN N.V. Key News
7.23 Randox Laboratories Ltd.
  7.23.1 Randox Laboratories Ltd. Corporate Summary
  7.23.2 Randox Laboratories Ltd. Business Overview
  7.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Major Product Offerings
  7.23.4 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.23.5 Randox Laboratories Ltd. Key News
7.24 Roche Holding AG
  7.24.1 Roche Holding AG Corporate Summary
  7.24.2 Roche Holding AG Business Overview
  7.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Major Product Offerings
  7.24.4 Roche Holding AG Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.24.5 Roche Holding AG Key News
7.25 Royal Philips N.V.
  7.25.1 Royal Philips N.V. Corporate Summary
  7.25.2 Royal Philips N.V. Business Overview
  7.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Major Product Offerings
  7.25.4 Royal Philips N.V. Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.25.5 Royal Philips N.V. Key News
7.26 Siemens AG
  7.26.1 Siemens AG Corporate Summary
  7.26.2 Siemens AG Business Overview
  7.26.3 Siemens AG Precision Cancer Diagnostic Tests Major Product Offerings
  7.26.4 Siemens AG Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.26.5 Siemens AG Key News
7.27 Thermo Fisher Scientific
  7.27.1 Thermo Fisher Scientific Corporate Summary
  7.27.2 Thermo Fisher Scientific Business Overview
  7.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Major Product Offerings
  7.27.4 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.27.5 Thermo Fisher Scientific Key News
7.28 Vela Diagnostics
  7.28.1 Vela Diagnostics Corporate Summary
  7.28.2 Vela Diagnostics Business Overview
  7.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Major Product Offerings
  7.28.4 Vela Diagnostics Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
  7.28.5 Vela Diagnostics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Precision Cancer Diagnostic Tests Market Opportunities & Trends in Global Market
Table 2. Precision Cancer Diagnostic Tests Market Drivers in Global Market
Table 3. Precision Cancer Diagnostic Tests Market Restraints in Global Market
Table 4. Key Players of Precision Cancer Diagnostic Tests in Global Market
Table 5. Top Precision Cancer Diagnostic Tests Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Precision Cancer Diagnostic Tests Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Precision Cancer Diagnostic Tests Revenue Share by Companies, 2017-2022
Table 8. Global Companies Precision Cancer Diagnostic Tests Product Type
Table 9. List of Global Tier 1 Precision Cancer Diagnostic Tests Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Precision Cancer Diagnostic Tests Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Precision Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Precision Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Precision Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Precision Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Precision Cancer Diagnostic Tests Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Precision Cancer Diagnostic Tests Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Precision Cancer Diagnostic Tests Product Offerings
Table 32. Abbott Laboratories Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 33. Agilent Technologies Corporate Summary
Table 34. Agilent Technologies Precision Cancer Diagnostic Tests Product Offerings
Table 35. Agilent Technologies Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 36. Becton Dickinson and Company Corporate Summary
Table 37. Becton Dickinson and Company Precision Cancer Diagnostic Tests Product Offerings
Table 38. Becton Dickinson and Company Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 39. Bio-Rad Laboratories Corporate Summary
Table 40. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Product Offerings
Table 41. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 42. Biocartis N.V. Corporate Summary
Table 43. Biocartis N.V. Precision Cancer Diagnostic Tests Product Offerings
Table 44. Biocartis N.V. Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 45. Biocept Corporate Summary
Table 46. Biocept Precision Cancer Diagnostic Tests Product Offerings
Table 47. Biocept Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 48. bioMerieux SA Corporate Summary
Table 49. bioMerieux SA Precision Cancer Diagnostic Tests Product Offerings
Table 50. bioMerieux SA Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 51. Canon Medical Systems Corporation Corporate Summary
Table 52. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Product Offerings
Table 53. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 54. Cynvenio Biosystems Corporate Summary
Table 55. Cynvenio Biosystems Precision Cancer Diagnostic Tests Product Offerings
Table 56. Cynvenio Biosystems Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 57. Danaher Corporation Corporate Summary
Table 58. Danaher Corporation Precision Cancer Diagnostic Tests Product Offerings
Table 59. Danaher Corporation Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 60. Epigenomics AG Corporate Summary
Table 61. Epigenomics AG Precision Cancer Diagnostic Tests Product Offerings
Table 62. Epigenomics AG Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 63. Exosome Diagnostics Corporate Summary
Table 64. Exosome Diagnostics Precision Cancer Diagnostic Tests Product Offerings
Table 65. Exosome Diagnostics Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 66. Foundation Medicine Corporate Summary
Table 67. Foundation Medicine Precision Cancer Diagnostic Tests Product Offerings
Table 68. Foundation Medicine Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 69. General Electric Company Corporate Summary
Table 70. General Electric Company Precision Cancer Diagnostic Tests Product Offerings
Table 71. General Electric Company Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 72. Genomic Health Corporate Summary
Table 73. Genomic Health Precision Cancer Diagnostic Tests Product Offerings
Table 74. Genomic Health Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 75. Hologic Corporate Summary
Table 76. Hologic Precision Cancer Diagnostic Tests Product Offerings
Table 77. Hologic Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 78. Illumina Corporate Summary
Table 79. Illumina Precision Cancer Diagnostic Tests Product Offerings
Table 80. Illumina Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 81. Menarini Silicon Biosystems SpA Corporate Summary
Table 82. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Product Offerings
Table 83. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 84. Myriad Genetics Corporate Summary
Table 85. Myriad Genetics Precision Cancer Diagnostic Tests Product Offerings
Table 86. Myriad Genetics Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 87. NanoString Technologies Corporate Summary
Table 88. NanoString Technologies Precision Cancer Diagnostic Tests Product Offerings
Table 89. NanoString Technologies Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 90. Ortho Clinical Diagnostics Corporate Summary
Table 91. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Product Offerings
Table 92. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 93. QIAGEN N.V. Corporate Summary
Table 94. QIAGEN N.V. Precision Cancer Diagnostic Tests Product Offerings
Table 95. QIAGEN N.V. Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 96. Randox Laboratories Ltd. Corporate Summary
Table 97. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Product Offerings
Table 98. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 99. Roche Holding AG Corporate Summary
Table 100. Roche Holding AG Precision Cancer Diagnostic Tests Product Offerings
Table 101. Roche Holding AG Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 102. Royal Philips N.V. Corporate Summary
Table 103. Royal Philips N.V. Precision Cancer Diagnostic Tests Product Offerings
Table 104. Royal Philips N.V. Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 105. Siemens AG Corporate Summary
Table 106. Siemens AG Precision Cancer Diagnostic Tests Product Offerings
Table 107. Siemens AG Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 108. Thermo Fisher Scientific Corporate Summary
Table 109. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Product Offerings
Table 110. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 111. Vela Diagnostics Corporate Summary
Table 112. Vela Diagnostics Precision Cancer Diagnostic Tests Product Offerings
Table 113. Vela Diagnostics Precision Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Precision Cancer Diagnostic Tests Segment by Type in 2021
Figure 2. Precision Cancer Diagnostic Tests Segment by Application in 2021
Figure 3. Global Precision Cancer Diagnostic Tests Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Precision Cancer Diagnostic Tests Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Precision Cancer Diagnostic Tests Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Precision Cancer Diagnostic Tests Revenue in 2021
Figure 8. By Type - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
Figure 9. By Application - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
Figure 10. By Region - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
Figure 11. By Country - North America Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
Figure 12. US Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
Figure 16. Germany Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 17. France Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
Figure 24. China Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 28. India Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
Figure 30. Brazil Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
Figure 33. Turkey Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Precision Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Agilent Technologies Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Becton Dickinson and Company Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bio-Rad Laboratories Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Biocartis N.V. Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Biocept Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. bioMerieux SA Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Cynvenio Biosystems Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Danaher Corporation Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Epigenomics AG Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Exosome Diagnostics Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Foundation Medicine Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. General Electric Company Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Genomic Health Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Hologic Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Illumina Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Myriad Genetics Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. NanoString Technologies Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. QIAGEN N.V. Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 60. Roche Holding AG Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 61. Royal Philips N.V. Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 62. Siemens AG Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 63. Thermo Fisher Scientific Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 64. Vela Diagnostics Precision Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)